Purchase Order 75N91023P00852
Award Date
9/14/23
Potential Completion Date
2/5/24
Potential Value
$30K
Federal Agency
National Cancer Institute
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $3,800.00, is for custom monoclonal antibody production services to support NIAID's biomedical research and public health initiatives. This contract does not have a set-aside designation. Genscript...
Genscript USA Inc. has been awarded a $24,705 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide services for creating customized monoclonal antibodies and plasmids in support of the agency's biomedical research efforts. As the prime contractor, Genscript will leverage its expertise in gene synthesis and monoclonal antibody development to deliver the requested biological products and services. This contract...
This is a $10,417.90 firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), an agency within the U.S. Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The contract is for the provision of custom/monoclonal antibodies to support NICHD's biomedical research and public health initiatives. Genscript, which specializes in gene synthesis, protein production,...
This is a $29,998.04 firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The contract is for the production and purification of recombinant human antibodies against influenza A, which will support the mission of NIAID's Cellular Biology Section. This sole-source award was justified under the authority of FAR...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing. The contract has a potential value of $174,903.00 and a completion date of July 14, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services, which it has...
This is a $24,564.70 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for antibody fragment humanization services, which involves modifying antibody proteins to make them more suitable for human therapeutic use. The contract does not have a set-aside designation. Genscript has a history of providing specialized molecular biology services,...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company. The $118,272.00 contract is for the provision of customized antibody expressions and plasmid preparations to support biomedical research and public health initiatives. The award has a completion date of November 1, 2020 and does not include a set-aside designation. Genscript...
Genscript USA Inc. has been awarded a firm fixed price purchase order valued at twelve thousand fifty-four dollars and fifty cents ($12,054.50) by the National Institutes of Health's National Cancer Institute to conduct research in antibody engineering using DNA. The work will be performed in Piscataway, New Jersey through March 31st, 2024. No set-aside designation was applied to this contract for antibody engineering with DNA awarded by the Department of Health and Human Services agency to...
This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
This is a $1,147,346.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a for-profit biotechnology company. The contract is for customized biological services to support the development and testing of therapeutic antibody and vaccine candidates by NIAID's Vaccine Research Center. This includes services such as plasmid preparation, protein production, and gene to...